Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis

por Osses, Daniël F., Roobol, Monique J., Schoots, Ivo G.
Publicado 2019

Multivariable risk-based patient selection for prostate biopsy in a primary health care setting: referral rate and biopsy results from a urology outpatient clinic

por Osses, Daniël F., Alberts, Arnout R., Bausch, Gonny C. F., Roobol, Monique J.
Publicado 2018

Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies

por Osses, Daniël F., Arsov, Christian, Schimmöller, Lars, Schoots, Ivo G., van Leenders, Geert J.L.H., Esposito, Irene, Remmers, Sebastiaan, Albers, Peter, Roobol, Monique J.
Publicado 2020

Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant...

por Schoots, Ivo G., Osses, Daniel F., Drost, Frank-Jan H., Verbeek, Jan F. M., Remmers, Sebastiaan, van Leenders, Geert J. L. H., Bangma, Chris H., Roobol, Monique J.
Publicado 2018

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?

por Osses, Daniël F., Drost, Frank‐Jan H., Verbeek, Jan F.M., Luiting, Henk B., van Leenders, Geert J.L.H., Bangma, Chris H., Krestin, Gabriel P., Roobol, Monique J., Schoots, Ivo G.
Publicado 2020